Newest added products
| 编号 | 化学名称 | Cas号 | 纯度 | 化学结构 |
|---|---|---|---|---|
| 25149 | Safusidenib | 1898206-17-1 | ≧98.0% |  |
| Safusidenib，也称为DS-1001，是一种口服异柠檬酸脱氢酶[NADP]细胞质（ | ||||
| 237072 | AZD0095 | 2750001-23-9 | ≧98.0% |  |
| AZD0095 is a Selective Inhibitor of Monocarboxylate Transporter 4 (MCT4) for Oncology. | ||||
| 20577 | LY-3522348 | 2568608-48-8 | ≧98.0% |  |
| LY-3522348是一种酮己糖激酶（KHK）抑制剂. | ||||
| 24069 | Tuvusertib | 1613200-51-3 | ≧98.0% |  |
| Tuvusertib, also known as M-1774 and ATR inhibitor 1, is a ATR inhibitor. M1774 selec | ||||
| 24129 | 2-MNG | 2101538-28-5 | ≧98.0% |  |
| 2-巯基烟酰甘氨酸是一种新型强效黑素生成抑制剂，具有独特的作 | ||||
| 25091 | Rilzabrutinib ( PRN1008 ) | 1575591-66-0 | ≧98.0% | _1575591-66-0.png) |
| Rilzabrutinib ( PRN1008 ) 是一种口服、可逆、共价的布鲁顿酪氨酸激酶 | ||||
| 25147 | GSK4362676 ( MAT2A-IN-9 ) | 2439277-80-0 | ≧98.0% |  |
| MAT2A-IN-9 ( GSK4362676 )是一种2-氧代喹唑啉衍生物，是一种强效的MAT2 | ||||
| 25150 | Ranosidenib | 2301974-60-5 | ≧98.0% |  |
| Ranosidenib，也称为HMPL-306，是一种异柠檬酸脱氢酶（IDH）抑制剂。 | ||||
| 25171 | Alnodesertib ( 同义词: ART0380 ) | 2267316-76-5 | ≧98.0% | .png) |
| 25172 | Amcasertib (同义词: BBI503) | 1129403-56-0 | ≧98.0% |  |
| 25173 | Anatibant (同义词: LF 16-0687; XY-2405) | 209733-45-9 | ≧98.0% | _209733-45-9.png) |
| 25174 | Catadegbrutinib (同义词: BGB-16673; BTK-IN-29) | 2736508-60-2 | ≧98.0% |  |